has got tremendous Research and Development application in Industry and moreover it has the ability to adjudicate various queries in the field of pharmaceutical sciences. Out of my own volition I have chosen Pharmaceutical Sciences‚ which offers ample scope for research activities and these parallels with my aspiration of a M.S. Degree. Pharmaceutical Sciences is considered with the study of the scientific study of the composition‚ properties‚ and activities of substances‚ Drugs and the changes
Premium Pharmacology Science Pharmacy
SUMMARY This case outlines the difficulty faced by Eli Lilly‚ a pharmaceutical company’s decision as to whether they should develop a lead migraine compound. This decision is faced by the Project Manager Bianca Sharma and she has to make recommendations in the PTAC meeting. A number of things have to be considered like- time to market‚ diversity of leads‚ traditional or combinatorial chemistry etc. which is unique to the pharmaceutical industry. Other factors which might not be unique to this industry
Premium Pharmaceutical industry Drug discovery Clinical trial
Novop A Th Printin l Healt Tularik cide Semco Bioscie n ce InterBio Mapping 15 years of M&A deals in the pharmaceuticalsSybindustry ron Bio harm chemic als - Clairol DuPon Bulk V ita Busine min ss nse 40 Archim e Pharm des a Pharmaceuticals Mergers & Acquisitions Chiron Diagno stics Anima lH Divisio ealth n DowEla Cordis Actimis BASF Ta Vitamin keda KK ex PCS H ea System lth s ordisk Amgen F Operati remont ons Amgen KK Millenn iu Pharm m a Abgen OTC Insecti Novart is
Premium Pharmaceutical industry Mergers and acquisitions Novartis
of the Pharmaceutical sector In the year 2004‚ the global economy experienced a momentum. After the dot.com bubble and the 9/11 terrorist attacks‚ the economy slowed down‚ especially in the USA. The American economy‚ which was the greatest market for the pharmaceutical industry‚ suffered an economic recession from 2001 to 2003. However‚ in 2004 the tax cuts and the lower interest rates stimulated a robust expansion in that country. Particularly‚ the worldwide sales in pharmaceutical products
Premium Pharmaceutical industry
ingredients and adjuvant for the purpose of adulteration. It is estimated that the economic loss due to drug-counterfeiting is 75 billion US dollars in 2010. Due to counterfeiting‚ pharmaceutical companies are deprived from their profit of developing and marketing the drugs. This may in turn lead to loss of interest by the pharmaceutical companies to develop more new and effective drugs in the
Premium Pharmacology Pharmaceutical drug Authentication
Access to essential medicines is therefore a right recognized as universal by the international community. But between what must be and what is‚ there is an immeasurable gap here‚ partly linked to the functioning of the pharmaceutical market. 3.4.2 Economic barriers to access to essential medicines Two major obstacles stand in the way of the equitable distribution of essential medicines: the problem of availability of medicines and their accessibility.93 • The availability
Premium Medicine Drug Pharmacology
decision‚ under what terms should Cambridge Laboratories move forward with the proposal from CPL? These questions are central to the firm because proteomics markers have the potential to become a major stream of revenue for Cambridge Labs. Pharmaceutical companies are starting proteomics programs and this market is projected to grow to $6 billion in 2005. Laboratory services have the potential to
Premium Strategic management Pharmaceutical industry
grocery store pharmacies. The outlook for the pharmaceutical field is fairly high in all parts of the country. With nearly 286‚400 people currently employed as Pharmacists across the United States‚ the growth is 3.7% higher than the average of all other career fields‚ meaning it is growing faster than average‚ therefore will need more and more people coming into the field. The average annual job openings are very high‚ at about 10‚980. The pharmaceutical field is already a large occupation and will
Premium Health care Pharmacology Marketing
in key growing therapeutic areas and focus on delivering patient-centric‚ innovative therapies. We seek strong‚ long-term relationships that fit our goals and offer a shared vision “ * Company Background: Pfizer is a research-based global pharmaceutical company. The company discovers‚ develops‚ manufactures and markets medicines for humans and animals‚ as well as consumer products. In order To maximize new opportunities in biomedical research‚ and bring more innovative
Premium Pharmaceutical industry Generic drug
Danish Parvez Ahmed Saeed Khan Chandni Kumari Anum Ali Junejo Executive Summary This is a research on GlaxoSmithKline a pharmaceutical concern has been conducted to primarily understand two aspects. First is to comprehend the current strategy of the company and second is to suggest an apt strategy to the company after analyzing the conditions of the pharmaceutical industry and the political‚ social and legal environment at large. The report would
Premium Financial ratio Financial ratios Pharmaceutical industry